Allergy Immunotherapies Market Forecast and Growth 2030

Allergy Immunotherapies Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment (Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT)), Allergy Type (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Geography

  • Report Code : TIPRE00008219
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Allergy Immunotherapies Market Dynamics - 2021 to 2031

Buy Now

The allergy immunotherapies market was estimated to be US$ 2.16 Bn in 2021 and US$ xx Bn in 2023. It is expected to reach US$ 5.11 Bn by 2031 and record a CAGR of 9.0% until 2031. Development of new delivery methods, rise of combination therapies, advancements in personalised medicine will likely remain key allergy immunotherapies market trends.

Allergy Immunotherapies Market Analysis

Increasing prevalence of allergic disorders worldwide is expected to drive the allergy immunotherapies market's growth. The growing prevalence of allergic disorders demands allergy immunotherapy, which is a safe and effective treatment against allergens such as insect molds, pollen, and animals, as well as for allergic asthma.  As per the American College of Allergy, Asthma & Immunology, in 2021, 1 in 3 adults and over 1 in 4 children in the US have reported having a seasonal allergy, eczema or food allergy.

The growing prevalence of allergies across the globe is raising the global demand for immunotherapies, which favors the growth of the market.

Allergy Immunotherapies Market Overview

The global allergy immunotherapies market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The market growth in this region is expected due to factors such as the increasing prevalence of allergic disorders and technological advancements in sublingual dosage formulations. However, drawbacks associated with the use of allergy immunotherapies and regulatory variations across regions are likely to hamper the market growth during the forecast period.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Allergy Immunotherapies Market: Strategic Insights

Allergy Immunotherapies Market

  • CAGR (2023 - 2031)
    9.0%
  • Market Size 2021
    US$ 2.16 Billion
  • Market Size 2031
    US$ 5.11 Billion

Market Dynamics

GROWTH DRIVERS
  • Growing Prevalence of Allergic Disorders
FUTURE TRENDS
  • Presence of Strong Product Pipeline
OPPORTUNITIES
  • Increasing FDA Approvals for Drugs

Key Players

  • ALK-Abelló A/S
  • Nestlé Health Science
  • LETIPharma
  • Stallergenes Greer
  • HAL Allergy B.V.
  • Johnson and Johnson Services, Inc.
  • Anergis
  • DBV Technologies
  • Dermapharm Holding
  • Allergy Therapeutics

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Treatment
  • Subcutaneous Immunotherapy
Type
  • Allergic Rhinitis
  • Asthma
  • Food Allergy
  • Venom Allergy
  • Others
Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Allergy Immunotherapies Market Drivers and Opportunities

Growing Awareness of Allergy Treatment is Likely to Favor The Market.

Increased public awareness about allergies and their management options fuels demand for better treatments. People seek relief from symptoms that can significantly impact their quality of life.

The Office of the State Superintendent of Education (OSSE) and the Division of Health & Wellness celebrated Food Allergy Awareness Week from May 14 to May 20, 2023. The campaign focused on educating and raising awareness about food allergies and anaphylaxis.

Presence of Strong Product Pipeline – An Opportunity in Allergy Immunotherapies Market

The allergy immunotherapy pipeline consists of 15 therapies in different clinical stages of development. Some of the players involved in the development of immunotherapies for allergic diseases are Aimmune Therapeutics Inc., DBV Technologies S.A., Genentech Inc., ASIT biotech SA, Inmunotek SL, Anergis S.A., Biomay AG, and Regeneron Pharmaceuticals Inc.

Positive clinical results of various immunotherapies undergoing clinical trials support the development of allergy immunotherapy-based drugs. For instance, in November 2022, the Food and Drug Administration (FDA) granted Fast Track designation to Alladapt Immunotherapeutic’s ADP101- an investigational oral immunotherapy for treating one or more of the most significant food allergens

Allergy Immunotherapies Market Report Segmentation Analysis

Key segments that contributed to the allergy immunotherapies market analysis derivation are services and applications.

  • Based on treatment, the allergy immunotherapies market is segmented into subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT). In 2023, the subcutaneous immunotherapy (SCIT) segment held the largest share of the market. Moreover, the sublingual immunotherapy (SLIT) segment is expected to grow at the fastest rate during the forecast period.
  • By allergy type, allergy immunotherapies market is segmented into allergic rhinitis, asthma, food allergy, venom allergy, and others. The allergic rhinitis segment held the largest share of the market in 2023, and the same segment is anticipated to register the highest CAGR in the market during the forecast period.
  • The allergy immunotherapies market has been segmented by distribution channel into hospital pharmacy, retail pharmacy, and online pharmacy. In 2023, the hospital pharmacy settings segment held the largest share of the market by distribution channel. Moreover, the same segment is expected to grow fastest during the forecast period.

Allergy Immunotherapies Market Share Analysis by Geography

The geographic scope of the allergy immunotherapies market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.

North America includes US, Canada, and Mexico. North America holds the most significant share in the allergy immunotherapies market, with the US holding the largest market share, followed by Canada. The US holds the largest share of the allergy immunotherapies market attributed to the growing prevalence of allergic disorders, thereby increasing the demand for allergy immunotherapy and fueling the market's growth. Moreover, it is headquarters for many manufacturers engaged in the manufacturing of allergy immunotherapy, further driving the growth of the market in the country. Moreover, rising consumer awareness regarding allergy treatment has increased demand for health supplemental oxygen in North America.

Asia Pacific region is expected to be the fastest-growing region among all other regions. The growth of the market in the Asia Pacific region is expected to grow at a faster pace owing to factors such as the high prevalence of allergic and immunology diseases in countries such as Australia, India, and others. Furthermore, increasing initiatives adopted by the government in terms of prevention and treatment strategies are expected to provide a lucrative market growth scenario in the region. Additionally, developing healthcare infrastructure and increasing investments to boost research activities are projected to drive the Asia Pacific Allergy Immunotherapies Market during the forecast period.

Allergy Immunotherapies Market Report Scope

Report Attribute Details
Market size in 2021 US$ 2.16 Billion
Market Size by 2031 US$ 5.11 Billion
Global CAGR (2023 - 2031) 9.0%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Treatment
  • Subcutaneous Immunotherapy
By Type
  • Allergic Rhinitis
  • Asthma
  • Food Allergy
  • Venom Allergy
  • Others
By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • ALK-Abelló A/S
  • Nestlé Health Science
  • LETIPharma
  • Stallergenes Greer
  • HAL Allergy B.V.
  • Johnson and Johnson Services, Inc.
  • Anergis
  • DBV Technologies
  • Dermapharm Holding
  • Allergy Therapeutics
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

    Allergy Immunotherapies Market News and Recent Developments

    The allergy immunotherapies market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for allergy immunotherapies and strategies:

    • In August 2020, Nestlé Health Science acquired Aimmune Therapeutics. Aimmune's approved therapy Palforzia would expand Nestlé Health Science portfolio with first and only FDA-approved treatment to help reduce the frequency and severity of allergic reactions to peanuts in children. (Source: Company Press Release)
    • In September 2023, Stallergenes Greer entered into an agreement with Nestlé Health Science to harness the peanut allergy oral immunotherapy treatment Palforzia.  (Source: Company Press Release)

    Allergy Immunotherapies Market Report Coverage and Deliverables

    The “Allergy Immunotherapies Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Market dynamics such as drivers, restraints, and key opportunities
    • Key future trends
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
    • Detailed company profiles
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    Treatment ; Allergy Type ; Distribution Channel , and Geography

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

    Trends and growth analysis reports related to Pharmaceuticals : READ MORE..